Delivery Order SPE2DB20D3104-SPE2DB23FV4R2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL. The $2,247.60 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., through the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive...
- This federal contract award is for the delivery of Humulin R 500 Unit/mL KwikPen 3mL to the Defense Logistics Agency (DLA). The $4,042.34 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL. The $10,628.96 firm-fixed price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award is for the delivery of Humulin R 500 unit/ml KwikPen 3ml to the Defense Logistics Agency (DLA). The $2,247.60 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the efficient procurement of a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $9,695.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Humulin R 500 unit/mL KwikPen 3mL medication. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has no set-aside designation, indicating it was competed on an open basis. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Humulin R 500 unit/ml Kwikpen 3ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,626.65, is a firm fixed-price delivery order with a completion date of November 12, 2021. It is not designated as a set-aside...
- This federal contract award is for the delivery of Humulin R insulin pens (500 unit/mL, 3mL) to the Defense Logistics Agency (DLA). The $1,123.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,553.81 for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract is funded by the Defense Logistics Agency (DLA), a defense agency, and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humulin R 500 Unit/mL Kwikpen 3mL, a specialty medication used for diabetes management. The contract has a ceiling value of $12,619.21 and a completion date of April 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Humulin R 500 unit/mL KwikPen 3mL to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $4,495.20 and an ultimate completion date of August 15, 2023. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp is a major...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV4R2Delivery Order
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humulin R 500 Unit/mL KwikPen 3mL. The contract, valued at $2,899.60, is a delivery order awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/10/23 |